Insider Buying: ASP Isotopes Inc. (NASDAQ:ASPI) Director Buys 9,500 Shares of Stock

ASP Isotopes Inc. (NASDAQ:ASPI) Director Robert John Andrew Ryan acquired 9,500 shares of the business’s stock in a transaction that occurred on Thursday, April 25th. The stock was bought at an average cost of $3.42 per share, for a total transaction of $32,490.00. Following the completion of the purchase, the director now directly owns 546,555 shares in the company, valued at approximately $1,869,218.10. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

ASP Isotopes Stock Performance

ASPI stock traded down $0.23 during trading on Monday, reaching $3.21. 505,435 shares of the stock were exchanged, compared to its average volume of 589,183. The stock has a 50 day simple moving average of $3.71 and a 200-day simple moving average of $2.50. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $157.03 million, a P/E ratio of -6.55 and a beta of 5.04. ASP Isotopes Inc. has a twelve month low of $0.28 and a twelve month high of $4.97.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings data on Wednesday, April 10th. The company reported ($0.09) EPS for the quarter. The firm had revenue of $0.43 million for the quarter. As a group, sell-side analysts anticipate that ASP Isotopes Inc. will post -0.11 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, HC Wainwright upped their price target on ASP Isotopes from $5.25 to $5.50 and gave the stock a “buy” rating in a report on Wednesday, April 17th.

Institutional Trading of ASP Isotopes

An institutional investor recently bought a new position in ASP Isotopes stock. HTLF Bank acquired a new position in shares of ASP Isotopes Inc. (NASDAQ:ASPI) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 78,538 shares of the company’s stock, valued at approximately $141,000. HTLF Bank owned approximately 0.16% of ASP Isotopes as of its most recent filing with the Securities and Exchange Commission. 16.80% of the stock is currently owned by institutional investors.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.